2025年第13届国际艾滋病学会(IAS)HIV科学会议

◆ 会议时间：2025年7月14-17日
◆ 会议地点：卢旺达 基加利

◆ 会议简介：

2025年第13届国际艾滋病学学会(IAS)HIV科学会议将于在2025年7月14-17日在卢旺达基加利举行，会议由国际艾滋病学协会(IAS)主办。IAS HIV科学会议是世界上最具影响力的关于HIV研究及其应用的会议，两年一届的会议将介绍在基础、临床等方面HIV研究取得的重要进展，这些研究将科学融入到政策和实践中；预计将有来自全球100多个国家的6,000余名科学家、临床医生、公共卫生专家和社区领导人出席会议。

国际艾滋病协会(IAS)成立于1988年，是世界上最大的HIV专业人士协会，成员遍布全球170多个国家和地区。IAS通过与成员合作一起倡导并采取紧急行动来减少HIV的影响。IAS组织世界上最负盛名的HIV会议：国际AIDS大会，IAS HIV科学会议和HIV研究与预防大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

IAS 2025 – 13th IAS Conference on HIV Science – International AIDS Society

Date：
14 – 17 July 2025

Venue:
Kigali Convention Centre
Kigali, Rwanda

The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.

摘要征文投稿：

Abstract Submission

Important dates

20 November 2024
Online abstract submission opens.

22 January 2025, 23:59 Central European Time
Abstract submission closes. Abstracts, as well as amendments to submitted abstracts, will not be accepted after this date (except for late breakers).

8 April 2025
Late-breaker abstract submission opens.

29 April 2025
Late-breaker abstract submission closes.

点此提交摘要>>>Submit Abstract>>>

You can submit your abstracts only online via the conference account on our website. We will not consider submissions by fax, post or email.

All abstracts must be written in English.

It is your responsibility, as the author, to submit an abstract with the correct wording. Any errors in spelling, grammar or scientific fact in the abstract text will be reproduced exactly as you have typed them. Titles of abstracts selected for presentation will be subject to a spellcheck.

Conference account

Authors must create a conference account to submit an abstract. More than one abstract can be submitted through a conference account. After an abstract has been created, modifications can be made until 22 January 2025, 23:59 Central European Time.

Choosing a track category

The track category is the general heading under which the abstract will be reviewed and later published in the conference materials if accepted. During the submission process, you will be asked to select one track category for your abstract. Choose the track category that best describes the subject of the abstract.

Abstract structure

The conference offers two options for abstract submission:

Option 1

This is suitable for research conducted in all disciplines. Abstracts submitted under Option 1 should contain concise statements of:

• Background: Indicate the purpose and objective of the research, the hypothesis that was tested, or a description of the problem being analysed or evaluated.
• Methods: Describe the study period, setting and location, study design, study population, data collection and methods of analysis used.
• Results: Present as clearly and in as much detail as possible the findings and/or outcomes of the study. Please disaggregate data by age and gender where possible and summarize any specific results.
• Conclusions: Explain the significance of your study’s findings and/or outcomes for HIV prevention, treatment, care and/or support and future implications of the results.

The following review criteria will be used in scoring abstracts submitted under Option 1:

1. Impact: Does the study contribute meaningfully to the field as an original study or a useful confirmatory study? 

1. Science: Is the study/research design of high quality and sufficiently explained, including clearly stated questions, data sources, data collection procedures and appropriate analytic/methodological approach and with clear and consistent results? 

Option 2

This is suitable for lessons learnt through programme, project or policy implementation or management. Abstracts submitted under Option 2 should contain concise statements of:

• Background: Summarize the purpose, scope and objectives of the programme, project or policy.
• Description: Describe the programme, project or policy period, setting and location, structure, key population (if applicable) and activities and interventions undertaken in support of the programme, project or policy.
• Lessons learnt: Present as clearly and in as much detail as possible the findings and/or outcomes of the programme, project or policy. Include an analysis or evaluation of lessons learnt and best practices. Please summarize any specific results that support your lessons learnt and best practices.
• Conclusions/next steps: Explain the significance of the findings and/or outcomes of the programme, project or policy for HIV prevention, treatment, care and/or support and future implications of the results.

The following review criteria will apply to abstracts submitted under Option 2:

1. Impact: Does the study contribute meaningfully to the field as an original study or a useful confirmatory study? 

1. Science: Is the programme, project or policy implementation of high quality and sufficiently explained, including justified objective, detailed findings/outcomes, data sources and feasibility and with clear and consistent results?  

Disaggregation by sex and other demographic data in abstracts 

Authors are encouraged to provide a breakdown of data by gender identity and/or assigned sex at birth and other demographics, such as age, geographic region, racial/ethnic identity and/or other relevant demographic characteristics in submitted abstracts when appropriate. Your abstract should include the number and percentage of men and women who participated in your research or project (and additional breakdown by gender, age and/or ethnicity if appropriate). Results should be disaggregated by sex/gender and other relevant demographics. Analyses of any gender-based differences or any other differences between sub-populations should be provided in the Results or Lessons learnt sections if relevant.

Meaningful engagement of people living with HIV in research

The IAS actively encourages the submission of research that meaningfully engages and involves people living with HIV, fostering collaboration through co-authorship and presenting author roles, in alignment with the principles outlined in the UNAIDS Global Advocacy Policy Brief on the Greater Involvement of People Living with HIV (GIPA).

Font

Use a standard font, such as Arial, when formatting the text. This helps prevent special characters from getting lost when copying the text to the online abstract submission form. Ensure that you check the final abstract with the system’s preview function before submission, and edit or replace if necessary.

Word limits

The abstract is limited to 350 words. Titles are limited to 30 words.

A maximum of two tables and/or graphs or images can be included. A graph or image (in JPG, GIF or PNG, ideally 600dpi) counts as 50 words and a table counts as five words per row (50 words maximum).

Common reasons for abstract rejection:

• Abstract poorly written
• Not enough new information
• Clear objective and/or hypothesis missing
• Methods (either quantitative or qualitative) inadequate and/or insufficient to support conclusions
• Summary of essential results inadequate and/or missing
• Study conclusions not supported by the data
• Linkage between different parts of the abstract not comprehensible
• Duplicate or overlap with another abstract
• Study too preliminary or insufficient to draw conclusions
• Study originality lacking

Recommendations:

• Abstracts should disclose primary findings and avoid, whenever possible, promissory statements, such as “experiments are in progress” or “results/lessons learnt will be discussed”.
• If English is not your native language, arrange for a native English speaker to review your abstract before submission.

Submission confirmation

After submission of the abstract, a confirmation email will be sent to the abstract submitter. To receive confirmation, please ensure that your email provider does not mark emails from ias2025@abstractserver.com as spam. 

注册费：

In-person plus on-demand

* To register as a student/postdoc, you must be at least 18 years old and present proof of full-time enrolment at a recognized university or college at both the time of registration and during IAS 2025.

* To register as a young person, you must be between 18 and 25 (inclusive) years old at the time of the conference and present proof of age (official identity card stating your age).

On-demand (virtual only)